Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Budget improvement comes from insight into everyday spending. Monitor, categorize, and adjust habits to maximize savings and achieve financial targets.
25,649 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
U.S. stocks pulled back after signals that a ceasefire may be unraveling, lifting oil and turning traders toward safe...
Institutional optimism around Ethereum is rising as new neutral stewardship groups launch and major firms signal inte...
A fierce bidding war over Two Harbors tested UWM's strategy. This article explains why UWM walked away from harbors c...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
AI megatrends are reshaping portfolios, and Robinhood users are flocking to chipmakers. This guide highlights the thr...
A growing number of seniors report t-bills more than salary as short-term yields rise, complicating the Social Securi...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
June brought a tighter landscape for mortgage credit as government-backed programs pulled back, pushing the MBA’s MCA...
A T-Rex fossil nicknamed Gus sold for $50.1 million at auction, setting a new price record and signaling renewed dema...
Strategy's Phong Le anchors the firm's crypto stance to a debt-risk threshold at $8K–$10K, underscoring balance-sheet...